Jan 26, 2024, 08:48 AM by

Recognizing the critical role of artificial intelligence in accelerating drug discovery, Bio-IT World Conference & Expo is offering expanded content on this pivotal technology at its 23rd annual event.

Jan 26, 2024, 08:48 AM by

Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board

Jan 26, 2024, 08:48 AM by

MedPharm, Ltd. is announcing the addition of Daniel Morland to its Senior Leadership Team as Senior Director of Sales & Marketing. Dan has more than 15 years of experience in the pharmaceutical industry and will be based out of the company's Headquarters in Guildford, UK. He will directly oversee MedPharm's global commercial efforts.

Jan 26, 2024, 08:48 AM by

Jan 26, 2024, 08:48 AM by

Jan 26, 2024, 08:48 AM by

Jan 25, 2024, 09:01 AM by

Amerigo Scientific is pleased to announce the availability of their well-selection and high-quality optimized ELISA kits designed to accurately measure target-specific proteins with simplicity, reliability, and consistency.

Jan 25, 2024, 09:01 AM by

Jan 25, 2024, 09:01 AM by

Jan 25, 2024, 09:01 AM by

London North West University Healthcare NHS Trust (LNWH) unites multiple geographically distinct hospitals with PhenoTips’ cloud-hosted Genomic Health Record (GHR) to digitize genomics and deliver on "Our Way Forward" 5-year plan.

Jan 25, 2024, 09:01 AM by

Jan 25, 2024, 09:01 AM by

DoseMe, a leading provider of precision dosing software for Model Informed Precision Dosing (MIPD) and creators of DoseMeRx and DoseMe Analytics, today announces its company highlights for 2023 and outlook for 2024.

Jan 25, 2024, 01:00 AM by User Not Found

Bio-IT World | Investigators with The University of New Mexico (UNM) and the National Institutes of Health (NIH) have succeeded in developing a cholesterol-lowering vaccine that works independently of statins. It could become the next vaccine-based approach targeting PCSK9 (proprotein convertase subtilisin/kexin type 9 serine protease) to enter clinical trials.

Jan 24, 2024, 08:46 AM by

InSysBio launches the new Plugin for Sublime Text editor to highlight Heta language code. Heta project is InSysBio’s initiative for the development of infrastructure for modeling in pharmacology and systems biology. The Plugin provides an opportunity for Heta code markup and highlighting in the popular text editor Sublime Text. Heta compiler Online was presented to simplify user experience. Now it is possible to try Heta compiler without installation or any other additional steps.

Jan 24, 2024, 08:46 AM by

Verisense Health combined its wearable technology expertise and clinical research knowledge to satisfy this unmet market need.

Jan 24, 2024, 08:46 AM by

Unlocking the combined value of Offspring’s innovative pre-clinical solutions with Flagship’s clinical trial data-driven assay solutions

Jan 24, 2024, 08:46 AM by

AtlasXomicsand EpiCypher announce their partnership to develop CUT&Tag kits and assayservices for spatial epigenomics applications.

Jan 24, 2024, 08:46 AM by

Jan 24, 2024, 08:46 AM by

Leading biometrics CRO Phastar to share vast statistical expertise with biotechs working to build the drugs of the future London, UK and Durham, NC – January 23rd, 2024: Phastar, a global specialist biometrics contract research organization (CRO), has announced the launch of Stats Helpdesk, a new initiative designed to provide biotech companies with free access to its team of expert statisticians.

Jan 24, 2024, 08:46 AM by